Bristol-Myers Squibb Co.

BMYNYSE • USD
ThemeHealthcare - Oncology›Immunotherapy & Immuno-Oncology
63.64 USD
↘ 0.11 (0.17%)AT CLOSE (11:59 AM EDT)
63.54
↘ 0.10 (0.16%)
POST MARKET (AS OF 08:11 PM EDT)
Post Market
AS OF 08:11 PM EDT
63.54
↘ 0.10 (0.16%)
🔴Market: CLOSED

Bristol-Myers Squibb Co. (BMY) trades at $63.64 per share. Technicals currently rate "Sell" while our fundamental analysis reads "Neutral". Key drivers include exceptional Return on Equity (41.6%) and a bullish Golden Cross on the moving averages. On the valuation side, BMY appears attractively valued relative to sector peers across key multiples.

Technical & fundamental data as of Sep 11, 2026.

Open?$64.15
High?$64.20
Low?$63.27
Prev. Close?$63.75
Volume?7.1M
Avg. Volume?9.8M
VWAP?$63.48
Rel. Volume?0.72x
Bid / Ask
Bid?$63.40 × 100
Ask?$63.68 × 500
Spread?$0.28
Midpoint?$63.54
Valuation & Ratios
Market Cap?130.0B
Shares Out?2.0B
Float?2.0B
Float %?99.9%
P/E Ratio?14.01
P/B Ratio?5.82
EPS?$4.54
Dividend?3.92%
Ex-Dividend?N/A
News
Profile
Bristol Myers Squibb discovers, develops, and markets drugs for various therapeutic areas, such as cardiovascular, cancer, and immune disorders. A key focus for Bristol is immuno-oncology, where the firm is a leader in drug development. Bristol derives close to 70% of total sales from the US, showing a higher dependence on the US market than most of its peer group.
Themes
Healthcare - Oncology›Immunotherapy & Immuno-OncologyBiotech - Drug Development›Immunology & Autoimmune
Employees
32.5K
Market Cap
130.2B
Industry
PHARMACEUTICAL PREPARATIONS
Website
www.bms.com
Listed
1952-06-23
Address
ROUTE 206 AND PROVINCE LINE ROAD
PRINCETON, NJ 08543
Phone: (609) 252-4621
Technical OutlookSell
Strong SellNeutralStrong Buy
Long-Term (Tide)?– Neutral(0/3)
Medium-Term (Wave)?– Neutral(0/3)
Short-Term (Ripple)?▼ Bearish(-3/3)
MA Alignment?Mixed
Full Technical Analysis →
Fundamental OutlookNeutral
Strong SellNeutralStrong Buy
F-Score?
60
Z-Score?
60
Momentum?
77
Short Sent.?
57
Piotroski F-Score?5/9Mixed
Altman Z-Score?2.66Grey
Confidence?81%High
Full Fundamental Analysis →
Short InterestHigh
Short % of Float?2.16%Low
Short Interest?44.1M
Days to Cover?5.3
Free Float2.0B
Avg Daily Volume8.4M
Settlement Date2026-08-31
Financial Health
Current Ratio?1.53Adequate
Quick Ratio?1.38Adequate
Cash Ratio?0.47Low
Debt/Equity?1.93High
ValuationATTRACTIVELY VALUEDvs 10 peers + S&P 500
Score
89/100
P/E?
Peers
100
S&P
84
14.0CHEAP▾
P/B?
Peers
90
S&P
32
5.82FAIR▾
P/S?
Peers
91
S&P
55
2.64CHEAP▾
P/FCF?
Peers
100
S&P
85
11.4CHEAP▾
EV/EBITDA?
Peers
91
S&P
74
11.0CHEAP▾
EV/Sales?
Peers
100
S&P
56
3.34FAIR▾
Returns & Efficiency
ROE?
Peers
67
S&P
89
41.6%STRONG▾
ROA?
Peers
70
S&P
76
10.6%STRONG▾
Cash Flow & Enterprise
FCF?$11.4B
Enterprise Value?$164.4B
Fundamentals ratios updated end of day
MarketsMoversWatchlist